CLNN (Clene Inc.) Net Income

CLNN (Clene Inc.) - company brandmark

Demand for neurodegeneration therapy remains constant, rendering the business non-cyclical. Operating profit reflects this stability, with current levels sitting around -0.04. Clene Inc. develops low-cost nanocrystalline drugs, ensuring high production scalability. However, a comprehensive economic moat will only materialize following final FDA approval of its proprietary ALS treatments.

CLNN: clene.com Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for clene.com (CLNN)

- stock value and consensus price forecast:
Market Price Clene|CLNN - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Clene Inc.|CLNN - Total Company Value
- company book value details:
Net Assets per Single Share Clene|CLNN - Book Capitalization|Market-to-Book Ratio clene.com|CLNN - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio Clene Inc.|CLNN - Long-Term Debt to Capital|Current Liabilities to Capital Clene|CLNN - Company Total Debt|Debt to Net Assets Ratio Clene Inc.|CLNN - Company Long-Term Debts|Short-Term Debt Volume Clene|Immediate Liquidity Ratio clene.com
- earnings and valuation multiples information:
CLNN - Net Profit
Summary company analysis:Clene Nanomedicine (CLNN)
Brand item of Clene Inc.

For Clene Inc. (CLNN), which focuses on developing neuro-drugs without external M&A support, operational resilience depends critically on capital management efficiency. By analyzing the company's profits, investors track daily net income trends that reveal hidden cash flow gaps and margin quality, allowing for an assessment of the biotech's survival probability prior to a strategic acquisition by a pharma behemoth.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Company Net Income Axsome Therapeutics, Inc. (AXSM)|Company Net Income ACAD (ACADIA Pharma)|Net Profit XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Company Net Income|SUPN - Company Net Income|CPRX (catalystpharma.com) - Company Profit|DNLI: Net Profit|Company Net Income Harmony Biosciences Inc (HRMY)|Net Income BHVN|AMLX: Final Profit|Net Profit TRVI|Net Financial Result praxismedicines.com|Company Net Income Anavex Life Sciences Corp. AVXL|CBLL: Company Profit|Prothena Biosciences - Net Profit|Alector, Inc. (ALEC) - Net Income|ANNX (Annexon, Inc.) - Net Income|OMER - Net Financial Result|NGNE (Neurogene) - Net Profit|Net Income AC Immune S.A. (ACIU)|Company Net Income Voyager Pharma (VYGR)|Company Net Income NMRA (Neumora Corp)|Company Net Income Scilex Holding Company SCLX|TVGN: Company Profit|ACOG - Company Net Income|CGTX (cogrx.com) - Company Profit|Inhibikase (IKT) - Company Net Income|Company Profit SAVA|ASRT (Assertio Holdings) - Net Profit|Company Net Income Coya COYA|Net Income VTGN (Vistagen Therapeutics)|Net Profit ovidrx.com (OVID)|Company Net Income Acumen Pharma ABOS|Final Profit CRVO|ATHE - Company Net Income|Company Net Income PepGen Inc.|JUNS: Net Profit|Net Income Relmada Therapeutics Inc|Company Net Income Annovis Bio Corp|Company Net Income GRCE|Net Profit AIFF|KLTO - Company Net Income|Company Net Income NeuroSense Therapeutics Ltd. NRSN|RVPH: Company Profit|MetaVia, Inc. - Net Profit|Company Net Income NeurAxis Inc|HSDT (heliusmedical.com) - Net Income|Passage Bio - Final Profit|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Minerva Neurosciences Inc (NERV) - Net Financial Result|Company Net Income Athira (ATHA)|Addex - Company Profit|Net Profit ALZN (Alzamend Neuro)|CYCN - Net Income|PTIX: Net Income|Net Financial Result Pasithea Therapeutics KTTA|CRGT: Net Profit|Net Income Avenue Therapeutics Inc|Company Net Income Brainstorm Cell|Company Net Income CARA|Company Net Income Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Company Profit|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH: Company Profit|MRNS - Company Net Income|NKGN (nkgenbiotech.com) - Company Profit|NRBO: Net Profit|Company Net Income Sage Therapeutics Inc. (SAGE)|Net Income SNPX|Net Profit Trevena Inc|Company Net Income Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Final Profit|Company Net Income Cerevel Therapeutics, Inc. CERE